Oveisgharan S, Buchman AS, Yu L, et al. ε2ε4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology. 2018;90(24):e2127-e2134. doi:10.1212/WNL.0000000000005677
Mathys H, Adaikkan C, Gao F, et al. Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution. Cell Rep. 2017;21(2):366-380. doi:10.1016/j.celrep.2017.09.039
Ashok A, Naaz S, Kota LN, et al. Does retinoic acid reverse cell cycle dysregulation in Alzheimer’s disease lymphocytes?. Asian J Psychiatr. 2019;39:174-177. doi:10.1016/j.ajp.2018.08.010
Hong S, Stevens B. TREM2: Keeping Microglia Fit during Good Times and Bad. Cell Metab. 2017;26(4):590-591. doi:10.1016/j.cmet.2017.09.010
Petyuk VA, Chang R, Ramirez-Restrepo M, et al. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain. 2018;141(9):2721-2739. doi:10.1093/brain/awy215
Ofengeim D, Mazzitelli S, Ito Y, et al. RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2017;114(41):E8788-E8797. doi:10.1073/pnas.1714175114
Hohman TJ, Dumitrescu L, Barnes LL, et al. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018;75(8):989-998. doi:10.1001/jamaneurol.2018.0821
Chen R, Zhang J, Wu Y, et al. Monoacylglycerol lipase is a therapeutic target for Alzheimer’s disease. Cell Rep. 2012;2(5):1329-39. doi:10.1016/j.celrep.2012.09.030
Mostafavi S, Gaiteri C, Sullivan SE, et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer’s disease. Nat Neurosci. 2018;21(6):811-819. doi:10.1038/s41593-018-0154-9
Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23(9):1018-1027. doi:10.1038/nm.4397